[{"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-001", "question": "A 5-week-old term infant presents with extreme irritability, brisk pupillary light reflexes, and episodic generalized hypertonia with arching of the back. There is reportedly bilious vomiting after feeds and undigested formula in loose stools. Testing reveals a severe hyponatremia (115 mEq/L), hypochloremia, and hyperkalemia with severe metabolic acidosis. Ultrasound shows bladder wall thickening with bilateral hydroureteronephrosis but no posterior urethral valves. Plasma renin activity is markedly elevated, and serum cortisol is normal. Which of the following electrolyte management strategies is most specifically appropriate pending definitive diagnosis?", "options": ["Isotonic saline boluses followed by fluid restriction to prevent sodium loss", "Hypertonic saline with sodium polystyrene sulfonate and sodium bicarbonate", "Isotonic saline with fludrocortisone to promote renal sodium reabsorption", "Normal saline boluses and maintenance fluids with added sodium bicarbonate and potassium chloride", "Withhold all sodium and potassium, provide glucose-only intravenous fluids to minimize tubular electrolyte load"], "answer": "B", "answer_index": 1, "explanation": "This infant has classic pseudohypoaldosteronism type 1 (autosomal recessive multiple organ form) due to mutations in the epithelial sodium channel (ENaC) subunits. The key is severe renal salt-wasting with hyperkalemia and metabolic acidosis despite elevated aldosterone/renin. Correction requires hypertonic saline for severe hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for acidosis. Fludrocortisone is ineffective since the defect is in the aldosterone receptor/target. Saline alone worsens potassium and acidosis; glucose-only fluids would exacerbate hyponatremia and shock.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic presentation of systemic Pseudohypoaldosteronism Type 1 (PHA1), characterized by severe salt-wasting (hyponatremia, hyperkalemia, metabolic acidosis), elevated renin, and normal cortisol (ruling out Congenital Adrenal Hyperplasia). The presence of loose stools and undigested formula supports the systemic (autosomal recessive, ENaC mutation) form affecting the gut. The patient has symptomatic hyponatremia (seizures/hypertonia), requiring urgent correction. Option B is the only defensible answer: it addresses the symptomatic hyponatremia with hypertonic saline, treats the acidosis with bicarbonate, and manages hyperkalemia with a resin (sodium polystyrene sulfonate). While sodium polystyrene sulfonate carries a risk of intestinal necrosis in neonates (especially with GI symptoms), it is the only option that physiologically addresses the electrolyte derangements. Option A (fluid restriction) and E (withholding sodium) are contraindicated in salt-wasting. Option C (fludrocortisone) is ineffective because PHA1 is a condition of aldosterone resistance, not deficiency. Option D is fatal as it adds potassium to a hyperkalemic patient. Thus, B is the unique best answer despite the clinical nuance regarding resin safety.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic presentation of systemic Pseudohypoaldosteronism Type 1 (PHA1), characterized by severe salt-wasting (hyponatremia, hyperkalemia, metabolic acidosis), elevated renin, and normal cortisol (ruling out Congenital Adrenal Hyperplasia). The presence of loose stools and undigested formula supports the systemic (autosomal recessive, ENaC mutation) form affecting the gut. The patient has symptomatic hyponatremia (seizures/hypertonia), requiring urgent correction. Option B is the only defensible answer: it addresses the symptomatic hyponatremia with hypertonic saline, treats the acidosis with bicarbonate, and manages hyperkalemia with a resin (sodium polystyrene sulfonate). While sodium polystyrene sulfonate carries a risk of intestinal necrosis in neonates (especially with GI symptoms), it is the only option that physiologically addresses the electrolyte derangements. Option A (fluid restriction) and E (withholding sodium) are contraindicated in salt-wasting. Option C (fludrocortisone) is ineffective because PHA1 is a condition of aldosterone resistance, not deficiency. Option D is fatal as it adds potassium to a hyperkalemic patient. Thus, B is the unique best answer despite the clinical nuance regarding resin safety.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-002", "question": "A previously healthy 3-year-old boy is admitted with acute liver failure of unknown etiology. He develops progressive ascites, coagulopathy, and encephalopathy. While awaiting transplantation evaluation, he becomes increasingly tachycardic and hypotensive. Echocardiography shows a hyperdynamic left ventricle, increased cardiac output, and a dilated inferior vena cava with minimal respiratory variation. Pulmonary capillary wedge pressure is 6 mmHg, systemic vascular resistance is markedly low. Terlipressin is initiated but the child develops profound peripheral cyanosis and worsening respiratory distress. Which of the following is the most appropriate next step in management?", "options": ["Increase terlipressin dose and add IV norepinephrine", "Immediately stop terlipressin and start IV epoprostenol", "Stop terlipressin and initiate IV methylene blue bolus followed by infusion", "Perform emergent transjugular intrahepatic portosystemic shunt (TIPS)", "Add IV octreotide and midodrine while continuing terlipressin"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed hepatopulmonary syndrome (HPS) with profound intrapulmonary shunting, worsened by terlipressin-induced pulmonary vasoconstriction. Methylene blue inhibits nitric oxide-mediated vasodilation, improving hypoxemia and hemodynamics in HPS. Continuing terlipressin or adding norepinephrine exacerbates pulmonary hypertension and shunt. Epoprostenol worsens hypotension and shunting. TIPS is contraindicated in acute liver failure with encephalopathy. Octreotide/midodrine are ineffective for HPS and may worsen splanchnic ischemia.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a pediatric patient with acute liver failure and high-output physiology (low SVR) who deteriorates after terlipressin initiation. The specific finding of \\\"profound peripheral cyanosis\\\" in a patient on terlipressin strongly indicates drug-induced acral ischemia (excessive vasoconstriction), a known serious complication requiring immediate cessation of the drug. However, the explanation attributes the decline to Hepatopulmonary Syndrome (HPS) and suggests Methylene Blue as the treatment. This presents multiple fatal flaws: (1) HPS causes central cyanosis (hypoxemia due to shunting), not peripheral cyanosis (ischemia/stasis); (2) Methylene Blue is a vasoconstrictor (NO inhibitor) which would dangerously exacerbate peripheral ischemia; (3) Methylene Blue is not the standard-of-care first-line treatment for HPS or terlipressin toxicity. The item conflates signs of vasoconstrictor toxicity with HPS physiology and keys an experimental, potentially harmful intervention. No option represents standard medical management (stopping the offending agent and providing supportive care).\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a pediatric patient with acute liver failure and high-output physiology (low SVR) who deteriorates after terlipressin initiation. The specific finding of \"profound peripheral cyanosis\" in a patient on terlipressin strongly indicates drug-induced acral ischemia (excessive vasoconstriction), a known serious complication requiring immediate cessation of the drug. However, the explanation attributes the decline to Hepatopulmonary Syndrome (HPS) and suggests Methylene Blue as the treatment. This presents multiple fatal flaws: (1) HPS causes central cyanosis (hypoxemia due to shunting), not peripheral cyanosis (ischemia/stasis); (2) Methylene Blue is a vasoconstrictor (NO inhibitor) which would dangerously exacerbate peripheral ischemia; (3) Methylene Blue is not the standard-of-care first-line treatment for HPS or terlipressin toxicity. The item conflates signs of vasoconstrictor toxicity with HPS physiology and keys an experimental, potentially harmful intervention. No option represents standard medical management (stopping the offending agent and providing supportive care).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-003", "question": "A 34-year-old woman presents to the ED 48 hours after a mountain climbing expedition above 18,000 feet. She reports severe headache, ataxia, and intermittent confusion. She was placed on high-flow oxygen, given dexamethasone 10 mg IV, and planned for descent. While awaiting helicopter transport, she develops sudden-onset facial droop, right hemiparesis, and global aphasia. Vital signs: BP 158/92, HR 110, SpO2 92% on 15L non-rebreather (previously 82%). Non-contrast head CT is normal. Which of the following is the most appropriate immediate therapeutic intervention?", "options": ["Administer IV tissue plasminogen activator (tPA) per stroke protocol", "Hyperbaric oxygen therapy in a portable chamber at the current altitude", "Immediate rapid descent to below 8,000 feet while maintaining oxygen", "Initiate IV heparin for presumed cerebral venous sinus thrombosis", "Increase dexamethasone to 20 mg IV and add acetazolamide 500 mg IV"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-altitude cerebral edema (HACE) with focal neurological deficits mimicking stroke, likely from venous infarction or hemorrhage. At this extreme altitude, hyperbaric oxygen immediately reduces intracranial pressure while awaiting evacuation. tPA is contraindicated due to potential hemorrhagic component and unclear time of symptom onset. Descent is critical but will take time; in-transport hyperbaric therapy provides immediate benefit. Heparin risks hemorrhage in HACE. Increased steroids and acetazolamide are inadequate for acute deterioration with focal deficits.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically invalid due to a fatal internal contradiction regarding the clinical setting. The vignette places the patient in an \\\"ED\\\" with a \\\"Non-contrast head CT\\\" (implying a modern hospital facility), yet simultaneously describes a remote field scenario where the patient is \\\"awaiting helicopter transport\\\" and the intended best intervention is a \\\"portable chamber\\\" (Gamow bag). It is logistically impossible to have a CT scanner at 18,000 feet. Conversely, if the patient were in a hospital with CT capabilities (at lower altitude), a portable field chamber would not be the standard of care over fixed resources or critical care management. This incoherence makes the item unsolvable: the CT result rules out hemorrhage (pushing toward stroke/tPA considerations), but the field setting (pushing toward HACE/Gamow bag) precludes the existence of the CT. While the intended teaching point—that HACE can mimic stroke and tPA is contraindicated in favor of repressurization—is medically sound, the vignette is incoherent. To fix, the stem should place the patient at a high camp (removing the ED/CT details) and state that descent is temporarily impossible due to weather.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically invalid due to a fatal internal contradiction regarding the clinical setting. The vignette places the patient in an \"ED\" with a \"Non-contrast head CT\" (implying a modern hospital facility), yet simultaneously describes a remote field scenario where the patient is \"awaiting helicopter transport\" and the intended best intervention is a \"portable chamber\" (Gamow bag). It is logistically impossible to have a CT scanner at 18,000 feet. Conversely, if the patient were in a hospital with CT capabilities (at lower altitude), a portable field chamber would not be the standard of care over fixed resources or critical care management. This incoherence makes the item unsolvable: the CT result rules out hemorrhage (pushing toward stroke/tPA considerations), but the field setting (pushing toward HACE/Gamow bag) precludes the existence of the CT. While the intended teaching point—that HACE can mimic stroke and tPA is contraindicated in favor of repressurization—is medically sound, the vignette is incoherent. To fix, the stem should place the patient at a high camp (removing the ED/CT details) and state that descent is temporarily impossible due to weather.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-004", "question": "A 32-year-old G2P1001 at 31 weeks gestation presents with acute-onset severe abdominal pain and hypotension. Ultrasound shows a normal intrauterine pregnancy with fetal heart rate 140 bpm, but a large right adnexal complex mass with free fluid. She is taken emergently to OR for suspected ovarian torsion. Intraoperatively, the right ovary is necrotic and detorted but appears hemorrhagic with surface excrescences. Frozen section returns 'atypical cells, cannot rule out malignancy.' Which of the following is the most appropriate surgical management?", "options": ["Right oophorectomy only, preserve uterus and left adnexa", "Right oophorectomy with right pelvic lymph node sampling", "Right oophorectomy with infracolic omentectomy and pelvic washings", "Right salpingo-oophorectomy with left ovarian biopsy and appendectomy", "Proceed with total abdominal hysterectomy with bilateral salpingo-oophorectomy"], "answer": "C", "answer_index": 2, "explanation": "In pregnancy with suspected ovarian cancer, staging should be as complete as possible while preserving the pregnancy. Omentectomy and washings provide critical staging information without compromising uterine blood supply or requiring extensive dissection near the gravid uterus. Lymph node sampling is not recommended in pregnancy due to risk of hemorrhage near iliac vessels; full lymphadenectomy can wait until postpartum. Appendectomy is only indicated for mucinous tumors. Hysterectomy terminates pregnancy unnecessarily; ovarian biopsy of normal ovary is not indicated. Frozen section limitations necessitate complete staging for definitive management decisions.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette presents a 31-week pregnant patient with ovarian torsion and findings suspicious for malignancy (necrotic mass with surface excrescences, atypical frozen section). The clinical challenge is to balance oncologic management with fetal safety. Immediate hysterectomy (E) is inappropriate as it forces premature delivery without indication (e.g., uncontrollable hemorrhage). Biopsy of a normal contralateral ovary (D) is contraindicated due to risks of adhesions and infertility without improving staging yield. Lymphadenectomy (B) is generally avoided in the third trimester due to the gravid uterus obstructing the retroperitoneum and the high risk of hemorrhage from engorged pelvic vessels. Simple removal (A) is insufficient given the high suspicion of malignancy. Option C represents the standard 'limited staging' approach for ovarian cancer in pregnancy: removing the mass (oophorectomy/salpingo-oophorectomy) and obtaining washings and omentectomy for staging, which guides postoperative chemotherapy decisions while preserving the pregnancy. Although 'salpingo-oophorectomy' is the technically precise term for cancer surgery, 'oophorectomy' in this context implies removal of the affected adnexa, and C is the only option offering appropriate staging steps without contraindicated procedures.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette presents a 31-week pregnant patient with ovarian torsion and findings suspicious for malignancy (necrotic mass with surface excrescences, atypical frozen section). The clinical challenge is to balance oncologic management with fetal safety. Immediate hysterectomy (E) is inappropriate as it forces premature delivery without indication (e.g., uncontrollable hemorrhage). Biopsy of a normal contralateral ovary (D) is contraindicated due to risks of adhesions and infertility without improving staging yield. Lymphadenectomy (B) is generally avoided in the third trimester due to the gravid uterus obstructing the retroperitoneum and the high risk of hemorrhage from engorged pelvic vessels. Simple removal (A) is insufficient given the high suspicion of malignancy. Option C represents the standard 'limited staging' approach for ovarian cancer in pregnancy: removing the mass (oophorectomy/salpingo-oophorectomy) and obtaining washings and omentectomy for staging, which guides postoperative chemotherapy decisions while preserving the pregnancy. Although 'salpingo-oophorectomy' is the technically precise term for cancer surgery, 'oophorectomy' in this context implies removal of the affected adnexa, and C is the only option offering appropriate staging steps without contraindicated procedures.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-005", "question": "A 42-year-old man with treatment-resistant schizophrenia on clozapine 450 mg daily develops acute urinary retention and obtundation. He was recently started on diphenhydramine 50 mg nightly for insomnia. In the ED, temperature is 38.9°C, HR 128, BP 168/102. He is diaphoretic, rigid, and incontinent of urine with myoclonus. Creatine kinase is 12,000 U/L, white count 18,000/mm³. After stopping all medications, which of the following is the most specific initial treatment?", "options": ["IV dantrolene 2.5 mg/kg", "IV bromocriptine 2.5 mg three times daily", "Oral cyproheptadine 12 mg loading dose", "IV physostigmine 1-2 mg", "IV lorazepam 2 mg every hour"], "answer": "D", "answer_index": 3, "explanation": "This is anticholinergic delirium with clozapine-diphenhydramine toxicity mimicking neuroleptic malignant syndrome (NMS). Physostigmine reverses central anticholinergic toxicity and helps differentiate from NMS. Dantrolene is for malignant hyperthermia, not anticholinergic crisis. Bromocriptine may worsen psychosis and is ineffective for anticholinergic toxicity. Cyproheptadine is for serotonin syndrome. Lorazepam addresses agitation but doesn't reverse anticholinergic blockade. The urinary retention, myoclonus, and recent antihistamine addition suggest anticholinergic crisis rather than pure NMS, though clozapine can cause both.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette contains contradictory information that precludes a single best answer. The patient presents with hyperthermia, rigidity, diaphoresis, and significant creatine kinase elevation (12,000 U/L) in the setting of clozapine use, which strongly suggests Neuroleptic Malignant Syndrome (NMS). However, the key (Physostigmine) and rationale argue for anticholinergic toxicity. A critical discriminating feature of anticholinergic toxicity is anhidrosis ('dry as a bone'), yet the stem explicitly states the patient is 'diaphoretic.' Diaphoresis is a hallmark of NMS or Serotonin Syndrome, not anticholinergic toxicity. Furthermore, physostigmine is generally contraindicated in patients with significant QRS widening or unclear diagnoses involving tricyclic-like agents (clozapine has TCA-like properties) due to the risk of asystole. Treating a rigid, diaphoretic patient with CK of 12,000 using physostigmine is medically unsafe and incorrect. The stem mixes features of NMS (rigidity, diaphoresis, CK) with anticholinergic toxicity (retention, history), making the item internally inconsistent and the keyed answer medically indefensible.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette contains contradictory information that precludes a single best answer. The patient presents with hyperthermia, rigidity, diaphoresis, and significant creatine kinase elevation (12,000 U/L) in the setting of clozapine use, which strongly suggests Neuroleptic Malignant Syndrome (NMS). However, the key (Physostigmine) and rationale argue for anticholinergic toxicity. A critical discriminating feature of anticholinergic toxicity is anhidrosis ('dry as a bone'), yet the stem explicitly states the patient is 'diaphoretic.' Diaphoresis is a hallmark of NMS or Serotonin Syndrome, not anticholinergic toxicity. Furthermore, physostigmine is generally contraindicated in patients with significant QRS widening or unclear diagnoses involving tricyclic-like agents (clozapine has TCA-like properties) due to the risk of asystole. Treating a rigid, diaphoretic patient with CK of 12,000 using physostigmine is medically unsafe and incorrect. The stem mixes features of NMS (rigidity, diaphoresis, CK) with anticholinergic toxicity (retention, history), making the item internally inconsistent and the keyed answer medically indefensible.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-006", "question": "A 28-year-old woman with borderline personality disorder presents after ingesting 100 tablets of acetaminophen 500 mg. She presents 30 hours post-ingestion with normal vital signs and normal mental status. AST is 850 U/L, INR is 1.8, creatinine is 1.2 mg/dL. IV N-acetylcysteine (NAC) is initiated. Six hours into the infusion, she develops acute respiratory distress, wheezing, facial edema, and hypotension. After stopping NAC and administering diphenhydramine and methylprednisolone, her symptoms resolve. Her AST has risen to 2,100 U/L. Which of the following is the most appropriate next step?", "options": ["Continue NAC at a reduced rate with diphenhydramine premedication", "Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours", "Begin high-flux hemodialysis to remove acetaminophen and NAC", "Administer cimetidine 300 mg IV every 6 hours as NAC alternative", "Initiate IV L-ornithine L-aspartate and silibinin as hepatoprotective agents"], "answer": "B", "answer_index": 1, "explanation": "Oral NAC is equally effective as IV for acetaminophen toxicity and should be used when IV causes anaphylactoid reactions. Continuing IV NAC with premedication risks recurrent reaction and hypotension. Hemodialysis does not effectively remove acetaminophen or NAC metabolites. Cimetidine has limited evidence and insufficient hepatoprotection. L-ornithine and silibinin are unproven in acute overdose. Since the patient presented late with established hepatotoxicity, completion of NAC via oral route is critical for glutathione repletion despite initial reaction to IV formulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a patient with established acetaminophen-induced hepatotoxicity (late presentation, elevated AST/INR) who experiences a severe anaphylactoid reaction (hypotension, respiratory distress) to IV NAC. The standard of care for severe reactions (specifically involving hypotension or bronchospasm) is to discontinue the IV infusion. Since the patient still requires NAC due to evidence of hepatic injury, alternative administration is necessary. Switching to oral NAC (Option B) is the widely accepted guideline-based next step when IV NAC is contraindicated by a severe reaction and the gut is functional. Option A (restarting IV) is generally reserved for mild reactions (flushing/urticaria) or cases where oral is impossible; restarting after hypotension carries significant risk. Option C (hemodialysis) is not indicated as the primary management here; while acetaminophen is dialyzable, at 30 hours the parent drug level is likely low, and the priority is antidote administration, which dialysis would remove. Options D and E are not standard of care. The item is medically accurate, logically sound, and the key is correct.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a patient with established acetaminophen-induced hepatotoxicity (late presentation, elevated AST/INR) who experiences a severe anaphylactoid reaction (hypotension, respiratory distress) to IV NAC. The standard of care for severe reactions (specifically involving hypotension or bronchospasm) is to discontinue the IV infusion. Since the patient still requires NAC due to evidence of hepatic injury, alternative administration is necessary. Switching to oral NAC (Option B) is the widely accepted guideline-based next step when IV NAC is contraindicated by a severe reaction and the gut is functional. Option A (restarting IV) is generally reserved for mild reactions (flushing/urticaria) or cases where oral is impossible; restarting after hypotension carries significant risk. Option C (hemodialysis) is not indicated as the primary management here; while acetaminophen is dialyzable, at 30 hours the parent drug level is likely low, and the priority is antidote administration, which dialysis would remove. Options D and E are not standard of care. The item is medically accurate, logically sound, and the key is correct.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-007", "question": "A 65-year-old man with major depressive disorder and chronic back pain develops serotonin syndrome after starting tramadol. He is managed with discontinuation of serotonergic agents and supportive care. One week later, he develops acute severe myoclonus, rigidity, hyperthermia (40.2°C), and autonomic instability. He had been started on olanzapine 5 mg daily four days prior for agitation. Creatine kinase is 25,000 U/L. Which of the following pathophysiological mechanisms best explains this paradoxical deterioration?", "options": ["Dopamine receptor upregulation causing rebound hyperdopaminergic state", "Serotonin transporter internalization leading to synaptic serotonin accumulation", "Gamma-aminobutyric acid (GABA) depletion from prolonged muscle activity", "Malignant catatonia triggered by antipsychotic withdrawal", "N-methyl-D-aspartate (NMDA) receptor hypofunction secondary to serotonin depletion"], "answer": "E", "answer_index": 4, "explanation": "This represents the serotonin syndrome-neuroleptic malignant syndrome (NMS) overlap or 'serotonin-NMS syndrome' where serotonin depletion following serotonin syndrome predisposes to NMDA receptor hypofunction, creating vulnerability to NMS when antipsychotics are introduced. Dopamine upregulation doesn't occur this rapidly. Serotonin transporter internalization would reduce, not increase, serotonin. GABA depletion is not a recognized mechanism. Malignant catatonia typically evolves more slowly. The sequence of serotonin syndrome followed by antipsychotic exposure with severe hyperthermia and rigidity suggests NMDA hypofunction as the bridge between these syndromes.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: N (No answer defensible). Verdict on key: No defensible answer. The vignette describes a classic case of Neuroleptic Malignant Syndrome (NMS) precipitated by the initiation of olanzapine. The widely accepted, standard pathophysiological mechanism for NMS is central dopamine (D2) receptor blockade. This mechanism is not provided in the options. The keyed answer (E) proposes 'NMDA receptor hypofunction secondary to serotonin depletion,' which is a theoretical model regarding the spectrum of malignant catatonia and serotonin syndrome. While this hypothesis exists in specialized research literature, it is not the standard medical explanation for antipsychotic-induced NMS. Testing a niche theory while omitting the primary, consensus-based mechanism (D2 blockade) makes the item invalid for a general medical board exam. Option A is incorrect (NMS is hypodopaminergic). Option D is incorrect (triggered by initiation, not withdrawal). Option C is not the primary driver. Candidates cannot be expected to select an esoteric hypothesis over the missing standard answer. Minimal Fix: Replace Option E with 'Central dopamine D2 receptor blockade'.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: N (No answer defensible). Verdict on key: No defensible answer. The vignette describes a classic case of Neuroleptic Malignant Syndrome (NMS) precipitated by the initiation of olanzapine. The widely accepted, standard pathophysiological mechanism for NMS is central dopamine (D2) receptor blockade. This mechanism is not provided in the options. The keyed answer (E) proposes 'NMDA receptor hypofunction secondary to serotonin depletion,' which is a theoretical model regarding the spectrum of malignant catatonia and serotonin syndrome. While this hypothesis exists in specialized research literature, it is not the standard medical explanation for antipsychotic-induced NMS. Testing a niche theory while omitting the primary, consensus-based mechanism (D2 blockade) makes the item invalid for a general medical board exam. Option A is incorrect (NMS is hypodopaminergic). Option D is incorrect (triggered by initiation, not withdrawal). Option C is not the primary driver. Candidates cannot be expected to select an esoteric hypothesis over the missing standard answer. Minimal Fix: Replace Option E with 'Central dopamine D2 receptor blockade'.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-008", "question": "A 58-year-old man undergoes robotic-assisted laparoscopic prostatectomy for Gleason 4+3=7 adenocarcinoma. On postoperative day 2, he develops abdominal distension and ileus. CT scan demonstrates a 3 cm retroperitoneal urinoma at the vesicourethral anastomosis. A percutaneous drain is placed, output is 200 mL/day of urine. After two weeks, drain output remains 150 mL/day despite Foley catheter drainage. Retrograde cystogram shows no leak. Which of the following is the most appropriate intervention to achieve closure?", "options": ["Prolonged Foley catheter drainage for 4-6 weeks", "Endoscopic placement of double-J ureteral stent", "Percutaneous nephrostomy tube placement", "Endoscopic injection of fibrin glue at anastomotic site", "Surgical revision of vesicourethral anastomosis"], "answer": "A", "answer_index": 0, "explanation": "For persistent urinoma after prostatectomy with no evidence of active leak on cystogram, the urinoma represents a 'urinoma cavity' that must collapse and seal. Prolonged Foley drainage (4-6 weeks) allows gradual collapse and healing. Ureteral stent or nephrostomy diverts urine but doesn't address the dead space. Fibrin glue injection risks infection and rarely works for established cavities. Surgical revision carries high morbidity and is rarely needed for small persistent drainage. The key is recognizing that low-output drainage from a drain may represent residual cavity fluid rather than active leak, requiring time rather than invasive intervention.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item contains a fundamental logical contradiction and medical inaccuracy regarding the physics of the clinical scenario. The stem describes a patient with a drain output of 150 mL/day of urine for two weeks, totaling over 2 liters of fluid. The rationale claims this is 'residual cavity fluid' from a 3 cm urinoma (approximate volume 14 mL) and that the negative cystogram confirms no active leak. It is physically impossible for a 14 mL non-refilling cavity to produce 150 mL/day for 14 days; this volume definitively indicates an active urinary leak. Furthermore, a persistent urine leak with a negative cystogram (which evaluates the bladder and vesicourethral anastomosis) strongly suggests a ureteral injury/leak, for which a Foley catheter (Option A) is ineffective and a ureteral stent (Option B) or nephrostomy (Option C) would be the correct intervention. The key (A) requires the examinee to ignore the high volume of output and the implications of the negative cystogram, accepting a physically impossible premise. Therefore, no answer is defensible based on the contradictory facts provided.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item contains a fundamental logical contradiction and medical inaccuracy regarding the physics of the clinical scenario. The stem describes a patient with a drain output of 150 mL/day of urine for two weeks, totaling over 2 liters of fluid. The rationale claims this is 'residual cavity fluid' from a 3 cm urinoma (approximate volume 14 mL) and that the negative cystogram confirms no active leak. It is physically impossible for a 14 mL non-refilling cavity to produce 150 mL/day for 14 days; this volume definitively indicates an active urinary leak. Furthermore, a persistent urine leak with a negative cystogram (which evaluates the bladder and vesicourethral anastomosis) strongly suggests a ureteral injury/leak, for which a Foley catheter (Option A) is ineffective and a ureteral stent (Option B) or nephrostomy (Option C) would be the correct intervention. The key (A) requires the examinee to ignore the high volume of output and the implications of the negative cystogram, accepting a physically impossible premise. Therefore, no answer is defensible based on the contradictory facts provided.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-009", "question": "A 45-year-old woman with neurofibromatosis type 1 presents with progressive paraparesis over 3 months. MRI shows a large enhancing intradural extramedullary mass at T4-T7 displacing the spinal cord, with multiple neuroforaminal extensions. During resection, the tumor is found to be highly vascular and adherent to multiple nerve roots. Intraoperative monitoring shows loss of motor evoked potentials (MEPs) in the lower extremities after partial debulking. Which of the following is the most appropriate intraoperative response?", "options": ["Abort surgery and close; plan for postoperative stereotactic radiosurgery", "Continue resection; MEP loss may be temporary with tumor manipulation", "Administer high-dose methylprednisolone and continue with subtotal resection", "Obtain immediate intraoperative frozen section to rule out malignant transformation", "Switch to intracapsular ultrasonic aspiration to minimize nerve root traction"], "answer": "A", "answer_index": 0, "explanation": "In spinal schwannomas (common in NF1), persistent loss of MEPs during resection indicates significant spinal cord ischemia or injury, likely from vascular compromise of the anterior spinal artery via tumor feeders. Continuing risks permanent paraplegia. Temporary MEP changes typically recover within minutes; persistent loss mandates stopping. Steroids are inadequate for vascular injury. Frozen section doesn't change acute management. Ultrasonic aspiration still risks vascular injury. The appropriate approach is to stop, preserve neurological function, and use stereotactic radiosurgery for residual tumor, which is effective for schwannomas and avoids surgical morbidity.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a patient with NF1 undergoing resection of a complex spinal tumor (likely a neurofibroma or schwannoma) complicated by intraoperative loss of Motor Evoked Potentials (MEPs). MEP loss is a critical alarm indicating spinal cord ischemia or mechanical injury. The standard of care is to immediately stop tumor manipulation to prevent permanent paraplegia. Options B, C, and E all suggest continuing the resection (with or without adjuncts), which is contraindicated and dangerous when monitoring signals are lost. Option D is a diagnostic step that does not address the acute neurological threat. Option A is the only medically defensible action among the choices: aborting the surgery to prevent further injury. While the full clinical protocol involves pausing and optimizing hemodynamics before permanently aborting, 'Abort' is the correct directional choice compared to 'Continue'. Postoperative radiosurgery is a valid management strategy for residual benign spinal tumors.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a patient with NF1 undergoing resection of a complex spinal tumor (likely a neurofibroma or schwannoma) complicated by intraoperative loss of Motor Evoked Potentials (MEPs). MEP loss is a critical alarm indicating spinal cord ischemia or mechanical injury. The standard of care is to immediately stop tumor manipulation to prevent permanent paraplegia. Options B, C, and E all suggest continuing the resection (with or without adjuncts), which is contraindicated and dangerous when monitoring signals are lost. Option D is a diagnostic step that does not address the acute neurological threat. Option A is the only medically defensible action among the choices: aborting the surgery to prevent further injury. While the full clinical protocol involves pausing and optimizing hemodynamics before permanently aborting, 'Abort' is the correct directional choice compared to 'Continue'. Postoperative radiosurgery is a valid management strategy for residual benign spinal tumors.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-010", "question": "A 72-year-old man with Gleason 4+5=9 adenocarcinoma of the prostate, cT3bN1M0, completes definitive intensity-modulated radiation therapy (IMRT) to prostate and pelvis to 79.2 Gy with 2 years of androgen deprivation therapy (ADT). Six months after completing ADT, PSA rises to 5.2 ng/mL. Ga-68 PSMA PET/CT shows isolated PSMA-avid retroperitoneal lymph node measuring 1.8 cm at the aortocaval confluence, SUVmax 12.5. Which of the following represents the most appropriate definitive management?", "options": ["Salvage extended field radiotherapy to include the retroperitoneum", "Systemic therapy with enzalutamide or abiraterone", "Metastasis-directed stereotactic body radiotherapy (SBRT) to the involved node", "Retroperitoneal lymph node dissection", "Re-initiation of ADT with docetaxel chemotherapy"], "answer": "C", "answer_index": 2, "explanation": "For oligorecurrent prostate cancer with a single PSMA-avid node, metastasis-directed therapy with SBRT offers durable control with minimal toxicity compared to systemic therapy or extended field RT. The STOMP and ORIOLE trials support this approach. Extended field radiotherapy to abdomen would have significant bowel toxicity. Systemic therapy is premature for solitary metastasis. Retroperitoneal lymph node dissection carries morbidity and may not be curative. Re-initiating ADT with chemotherapy is overtreatment for oligometastatic disease. SBRT provides local control while delaying systemic therapy and its side effects.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with oligorecurrent prostate cancer (metachronous oligometastasis) manifesting as a single retroperitoneal lymph node on PSMA PET. The central clinical decision is selecting management that balances disease control with toxicity. The STOMP and ORIOLE trials support Metastasis-Directed Therapy (MDT), specifically SBRT (Option C), to improve ADT-free survival and delay the quality-of-life impact of restarting systemic therapy. Option A (Extended field RT) is unnecessarily toxic for a solitary recurrence. Options B and E are systemic therapies; while ADT or novel anti-androgens are standard for metastatic disease, the specific 'oligometastatic' framing and the request for 'definitive' (implying local/curative intent) management favor SBRT. Option D is a valid MDT but is more invasive than SBRT without proven superior oncologic benefit in this setting. A minor medical nuance is that 6 months post-2-year ADT, the patient may technically still be castrate (testosterone <50 ng/dL), which would classify this as mCRPC (where systemic therapy is the stronger standard); however, the option to 'Re-initiate ADT' implies the question assumes a hormone-sensitive or intermittent-ADT framework, making C the unambiguous best answer for the intended teaching point.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with oligorecurrent prostate cancer (metachronous oligometastasis) manifesting as a single retroperitoneal lymph node on PSMA PET. The central clinical decision is selecting management that balances disease control with toxicity. The STOMP and ORIOLE trials support Metastasis-Directed Therapy (MDT), specifically SBRT (Option C), to improve ADT-free survival and delay the quality-of-life impact of restarting systemic therapy. Option A (Extended field RT) is unnecessarily toxic for a solitary recurrence. Options B and E are systemic therapies; while ADT or novel anti-androgens are standard for metastatic disease, the specific 'oligometastatic' framing and the request for 'definitive' (implying local/curative intent) management favor SBRT. Option D is a valid MDT but is more invasive than SBRT without proven superior oncologic benefit in this setting. A minor medical nuance is that 6 months post-2-year ADT, the patient may technically still be castrate (testosterone <50 ng/dL), which would classify this as mCRPC (where systemic therapy is the stronger standard); however, the option to 'Re-initiate ADT' implies the question assumes a hormone-sensitive or intermittent-ADT framework, making C the unambiguous best answer for the intended teaching point.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-011", "question": "A 9-month-old exclusively breastfed infant presents with severe metabolic acidosis (pH 7.18), lactic acidosis, hyperammonemia (250 μmol/L), and hypoglycemia. Urine organic acids show elevated 3-hydroxyisovalerylcarnitine, 3-methylglutaconate, and 3-hydroxy-3-methylglutarate. Plasma acylcarnitine profile reveals elevated C5-OH. The infant develops acute neurological deterioration with abnormal eye movements. Which of the following is the most urgent specific intervention?", "options": ["IV carnitine 100 mg/kg", "IV riboflavin 100 mg", "IV biotin 10 mg", "Oral glycine 250 mg/kg", "IV sodium benzoate 250 mg/kg"], "answer": "C", "answer_index": 2, "explanation": "The biochemical profile indicates multiple carboxylase deficiency (biotinidase or holocarboxylase synthetase deficiency). Biotin is the cofactor for all four carboxylases, and high-dose IV biotin can rapidly reverse the metabolic crisis. Carnitine may help with secondary deficiency but doesn't address the primary defect. Riboflavin is for multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II). Glycine is for isovaleric acidemia. Sodium benzoate is for hyperammonemia but does not correct carboxylase deficiency. The neurological symptoms may include seizures and coma requiring emergent biotin administration before confirmatory enzyme testing.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a 9-month-old with metabolic acidosis, hyperammonemia, and hypoglycemia. The key diagnostic clues are the urine organic acids: elevated 3-hydroxy-3-methylglutarate (HMG) and 3-methylglutaconate, alongside plasma C5-OH. This specific profile is diagnostic of HMG-CoA Lyase Deficiency. In Multiple Carboxylase Deficiency (MCD)—the condition intended by the key (Biotin)—the metabolic block is at 3-methylcrotonyl-CoA carboxylase (upstream of HMG formation). Consequently, MCD presents with elevated 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, but *not* 3-methylglutaconate or HMG. The presence of HMG definitively rules out MCD. For HMG-CoA Lyase Deficiency, biotin is ineffective; management relies on glucose and protein restriction. While sodium benzoate (Option E) treats hyperammonemia, it is not the specific antidote for the underlying enzyme defect in the way Biotin is for MCD. Thus, the stem contains a fatal contradiction: the biochemical details describe a condition (HMG-CoA Lyase Deficiency) for which the keyed answer is incorrect. To fix, the organic acids should be changed to '3-hydroxyisovaleric acid and 3-methylcrotonylglycine' to match the MCD diagnosis and Biotin key.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a 9-month-old with metabolic acidosis, hyperammonemia, and hypoglycemia. The key diagnostic clues are the urine organic acids: elevated 3-hydroxy-3-methylglutarate (HMG) and 3-methylglutaconate, alongside plasma C5-OH. This specific profile is diagnostic of HMG-CoA Lyase Deficiency. In Multiple Carboxylase Deficiency (MCD)—the condition intended by the key (Biotin)—the metabolic block is at 3-methylcrotonyl-CoA carboxylase (upstream of HMG formation). Consequently, MCD presents with elevated 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, but *not* 3-methylglutaconate or HMG. The presence of HMG definitively rules out MCD. For HMG-CoA Lyase Deficiency, biotin is ineffective; management relies on glucose and protein restriction. While sodium benzoate (Option E) treats hyperammonemia, it is not the specific antidote for the underlying enzyme defect in the way Biotin is for MCD. Thus, the stem contains a fatal contradiction: the biochemical details describe a condition (HMG-CoA Lyase Deficiency) for which the keyed answer is incorrect. To fix, the organic acids should be changed to '3-hydroxyisovaleric acid and 3-methylcrotonylglycine' to match the MCD diagnosis and Biotin key.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-012", "question": "A 4-year-old boy with DiGeorge syndrome (22q11.2 deletion) develops pneumonia requiring hospitalization. He has previously undergone complete repair of tetralogy of Fallot and receives supplemental calcium and vitamin D for hypoparathyroidism. During hospitalization, he develops refractory hypocalcemia (ionized calcium 0.8 mmol/L) despite IV calcium gluconate. ECG shows prolonged QTc interval. Parathyroid hormone is undetectable. Which of the following electrolyte abnormalities most likely explains the calcium refractory to therapy?", "options": ["Hypomagnesemia (0.9 mg/dL)", "Hyperphosphatemia (8.2 mg/dL)", "Metabolic alkalosis (pH 7.48)", "Hyperkalemia (6.2 mEq/L)", "Hyponatremia (125 mEq/L)"], "answer": "A", "answer_index": 0, "explanation": "In DiGeorge syndrome with hypoparathyroidism, refractory hypocalcemia is most commonly due to hypomagnesemia, as magnesium is required for PTH secretion and end-organ response. Magnesium deficiency impairs both PTH release (already absent here) and the ability of administered PTH/calcium to maintain calcium levels. Hyperphosphatemia can lower calcium but doesn't cause refractoriness to IV calcium. Alkalosis increases protein binding but not true refractoriness. Hyperkalemia and hyponatremia don't directly affect calcium responsiveness. Magnesium repletion must precede effective calcium management in this setting.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe question describes a classic metabolic scenario: hypocalcemia that fails to correct with calcium supplementation ('refractory'). The key discriminator is the specific electrolyte abnormality known to cause this resistance. Hypomagnesemia (Option A, 0.9 mg/dL) is the standard medical cause for refractory hypocalcemia. Although the patient has DiGeorge syndrome with undetectable PTH (removing the 'impaired PTH secretion' mechanism of hypomagnesemia), magnesium is also required for the peripheral action of Vitamin D and general calcium homeostasis/bone exchange. Consequently, calcium levels often cannot be normalized until magnesium is repleted. Hyperphosphatemia (Option B) is expected in hypoparathyroidism and promotes calcium precipitation, but the specific descriptor 'refractory to IV calcium' is the board-exam buzzword for hypomagnesemia. Metabolic alkalosis (Option C) lowers ionized calcium but does not typically cause refractoriness to aggressive IV replacement. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe question describes a classic metabolic scenario: hypocalcemia that fails to correct with calcium supplementation ('refractory'). The key discriminator is the specific electrolyte abnormality known to cause this resistance. Hypomagnesemia (Option A, 0.9 mg/dL) is the standard medical cause for refractory hypocalcemia. Although the patient has DiGeorge syndrome with undetectable PTH (removing the 'impaired PTH secretion' mechanism of hypomagnesemia), magnesium is also required for the peripheral action of Vitamin D and general calcium homeostasis/bone exchange. Consequently, calcium levels often cannot be normalized until magnesium is repleted. Hyperphosphatemia (Option B) is expected in hypoparathyroidism and promotes calcium precipitation, but the specific descriptor 'refractory to IV calcium' is the board-exam buzzword for hypomagnesemia. Metabolic alkalosis (Option C) lowers ionized calcium but does not typically cause refractoriness to aggressive IV replacement. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-013", "question": "A 19-year-old competitive free-diver presents to the ED 60 minutes after a 45-meter dive. He developed chest pain and hemoptysis upon surfacing. He is tachycardic, hypotensive, and hypoxic. Chest CT shows bilateral ground-glass opacities and pneumomediastinum. He is intubated for worsening hypoxia. During mechanical ventilation, he develops sudden cardiovascular collapse with pulseless electrical activity. Which of the following is the most appropriate immediate intervention?", "options": ["Needle decompression of both chests", "Initiating venoarterial extracorporeal membrane oxygenation (ECMO)", "Immediate hyperbaric oxygen therapy", "Administering IV epinephrine 1 mg", "Performing pericardiocentesis"], "answer": "B", "answer_index": 1, "explanation": "This diver has arterial gas embolism (AGE) with catastrophic decompression sickness. Cardiovascular collapse in AGE represents massive air in coronary or cerebral arteries. ECMO provides immediate cardiopulmonary support while allowing time for bubble resolution and prevents further air aspiration during chest compressions. Needle decompression is for tension pneumothorax, not AGE. Hyperbaric oxygen is definitive but cannot be performed during cardiac arrest. Epinephrine may worsen air trapping through bronchodilation. Pericardiocentesis is not indicated without pericardial effusion. ECMO is increasingly used in diving-related catastrophic AGE as a bridge to hyperbaric treatment.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Miskeyed (K). Verdict: Miskeyed; Option A is the standard of care. The vignette describes a patient with known pulmonary barotrauma (pneumomediastinum) who suffers sudden PEA arrest after the initiation of positive pressure ventilation. This is the classic presentation of tension pneumothorax. Standard resuscitation guidelines (ACLS/ATLS) mandate immediate exclusion of tension pneumothorax via needle decompression or finger thoracostomy (Option A) before considering other causes. While massive Arterial Gas Embolism (AGE) is a valid differential, it cannot be clinically distinguished from tension pneumothorax in the arrest setting without decompression. Furthermore, ECMO (Option B) is a complex, time-consuming intervention appropriate for refractory arrest, not the 'most appropriate immediate intervention' superseding ABCs and H&Ts. The provided rationale also contains medical hallucinations, stating epinephrine (Option D) is contraindicated because 'bronchodilation may worsen air trapping,' which is physiologically incorrect and contrary to ACLS guidelines. Option A is the correct best answer for immediate action. Minimal fix: Change the clinical course to refractory arrest after decompression, or change the question to 'Which intervention is definitive for refractory AGE?'\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Miskeyed (K). Verdict: Miskeyed; Option A is the standard of care. The vignette describes a patient with known pulmonary barotrauma (pneumomediastinum) who suffers sudden PEA arrest after the initiation of positive pressure ventilation. This is the classic presentation of tension pneumothorax. Standard resuscitation guidelines (ACLS/ATLS) mandate immediate exclusion of tension pneumothorax via needle decompression or finger thoracostomy (Option A) before considering other causes. While massive Arterial Gas Embolism (AGE) is a valid differential, it cannot be clinically distinguished from tension pneumothorax in the arrest setting without decompression. Furthermore, ECMO (Option B) is a complex, time-consuming intervention appropriate for refractory arrest, not the 'most appropriate immediate intervention' superseding ABCs and H&Ts. The provided rationale also contains medical hallucinations, stating epinephrine (Option D) is contraindicated because 'bronchodilation may worsen air trapping,' which is physiologically incorrect and contrary to ACLS guidelines. Option A is the correct best answer for immediate action. Minimal fix: Change the clinical course to refractory arrest after decompression, or change the question to 'Which intervention is definitive for refractory AGE?'", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-014", "question": "A 28-year-old G2P0010 at 7 weeks gestation presents with vaginal bleeding and lower abdominal pain. Quantitative β-hCG is 850 mIU/mL. Transvaginal ultrasound shows no intrauterine gestational sac, normal bilateral ovaries, and minimal free fluid in the cul-de-sac. Two days later, repeat β-hCG is 1,100 mIU/mL. Diagnostic laparoscopy reveals a 1 cm blue-bulge on the left fallopian tube consistent with ectopic pregnancy. Which of the following is the most appropriate management?", "options": ["Systemic methotrexate (MTX) 50 mg/m²", "Salpingostomy with preservation of the fallopian tube", "Segmental resection of the affected tubal portion", "Salpingectomy", "Expectant management with weekly β-hCG monitoring"], "answer": "D", "answer_index": 3, "explanation": "For ectopic pregnancy with β-hCG <2000 and small size, MTX is usually first-line. However, this patient has already undergone diagnostic laparoscopy, making surgical management more appropriate than switching to medical therapy. Given she is G2P0 with no living children, preservation might be considered, but studies show similar future fertility with salpingectomy versus salpingostomy, and salpingectomy eliminates risk of persistent ectopic tissue. Segmental resection is for isthmic ectopics when anastomosis is planned. Expectant management is inappropriate with visualized ectopic. Salpingostomy carries 5-20% risk of persistent trophoblast requiring additional treatment. Salpingectomy provides definitive treatment during the established surgical encounter.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict on keyed answer: Correct best. The patient is intra-operative (diagnostic laparoscopy) with a visualized unruptured ectopic pregnancy. While Methotrexate (A) is a first-line option for stable, unruptured ectopics, it is generally inappropriate to abandon established surgical access to administer systemic medication, as surgery provides definitive treatment immediately. The decision lies between Salpingostomy (B) and Salpingectomy (D). Current consensus (e.g., ACOG Practice Bulletin 193, ESEP trial) states that salpingectomy is preferred when the contralateral tube is healthy, as it eliminates the risk of persistent trophoblast (which occurs in 5–20% of salpingostomies) and recurrent ectopic in that tube, while offering equivalent future fertility rates. Salpingostomy is typically reserved for patients with a damaged or absent contralateral tube. Since the vignette does not describe contralateral tubal pathology, Salpingectomy is the standard of care. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict on keyed answer: Correct best. The patient is intra-operative (diagnostic laparoscopy) with a visualized unruptured ectopic pregnancy. While Methotrexate (A) is a first-line option for stable, unruptured ectopics, it is generally inappropriate to abandon established surgical access to administer systemic medication, as surgery provides definitive treatment immediately. The decision lies between Salpingostomy (B) and Salpingectomy (D). Current consensus (e.g., ACOG Practice Bulletin 193, ESEP trial) states that salpingectomy is preferred when the contralateral tube is healthy, as it eliminates the risk of persistent trophoblast (which occurs in 5–20% of salpingostomies) and recurrent ectopic in that tube, while offering equivalent future fertility rates. Salpingostomy is typically reserved for patients with a damaged or absent contralateral tube. Since the vignette does not describe contralateral tubal pathology, Salpingectomy is the standard of care. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-015", "question": "A 55-year-old woman with treatment-resistant depression has been stable on phenelzine 60 mg daily for 3 years. She presents with acute confusion, fever (39.4°C), hypertonia, and myoclonus after starting amitriptyline 50 mg daily for neuropathic pain 5 days ago. Creatine kinase is 3,500 U/L. After discontinuing amitriptyline and providing supportive care, she develops persistent paranoid delusions and auditory hallucinations. Which of the following antipsychotics carries the LOWEST risk of precipitating serotonin syndrome or hypertensive crisis in this patient?", "options": ["Haloperidol", "Olanzapine", "Quetiapine", "Aripiprazole", "Brexpiprazole"], "answer": "C", "answer_index": 2, "explanation": "Quetiapine has the lowest serotonin reuptake inhibition among antipsychotics, minimizing serotonin syndrome risk when used with MAOIs. Haloperidol has minimal serotonergic effects but high dopamine blockade risks exacerbating parkinsonism after recent serotonin syndrome. Olanzapine has moderate serotonin 5-HT2A antagonism but minimal reuptake inhibition. Aripiprazole and brexpiprazole are partial agonists at 5-HT1A receptors and antagonists at 5-HT2A, with complex serotonergic profiles that could theoretically interact. Quetiapine's metabolite norquetiapine has norepinephrine reuptake inhibition but at therapeutic doses this is minimal. The priority is avoiding serotonergic agents while managing psychosis in a patient on irreversible MAOI.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Miskeyed (K). The question specifically asks which agent carries the LOWEST risk of precipitating serotonin syndrome (SS) or hypertensive crisis. Haloperidol (A) is a pure dopamine antagonist with no significant affinity for serotonin or norepinephrine transporters; it carries effectively zero risk of precipitating SS or hypertensive crisis (its primary cardiovascular risk is hypotension). The keyed answer, Quetiapine (C), has a major metabolite (norquetiapine) that acts as a norepinephrine reuptake inhibitor (NRI), which theoretically increases the risk of hypertensive crisis in a patient on an MAOI. Therefore, regarding the specific risks queried, Haloperidol is safer than Quetiapine. The rationale disqualifies Haloperidol based on 'parkinsonism risk,' a clinical consideration not requested in the stem. Furthermore, Olanzapine (B) is an SGA that lacks the NRI activity of Quetiapine, making it also safer regarding hypertensive crisis. The item is miskeyed because Option A is the most correct answer to the literal question asked, while the key (C) requires prioritizing an unstated criterion (EPS profile) over the stated criteria (SS/HTN risk).\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Miskeyed (K). The question specifically asks which agent carries the LOWEST risk of precipitating serotonin syndrome (SS) or hypertensive crisis. Haloperidol (A) is a pure dopamine antagonist with no significant affinity for serotonin or norepinephrine transporters; it carries effectively zero risk of precipitating SS or hypertensive crisis (its primary cardiovascular risk is hypotension). The keyed answer, Quetiapine (C), has a major metabolite (norquetiapine) that acts as a norepinephrine reuptake inhibitor (NRI), which theoretically increases the risk of hypertensive crisis in a patient on an MAOI. Therefore, regarding the specific risks queried, Haloperidol is safer than Quetiapine. The rationale disqualifies Haloperidol based on 'parkinsonism risk,' a clinical consideration not requested in the stem. Furthermore, Olanzapine (B) is an SGA that lacks the NRI activity of Quetiapine, making it also safer regarding hypertensive crisis. The item is miskeyed because Option A is the most correct answer to the literal question asked, while the key (C) requires prioritizing an unstated criterion (EPS profile) over the stated criteria (SS/HTN risk).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-016", "question": "A 23-year-old woman with schizoaffective disorder, bipolar type, maintained on lithium 900 mg daily and paliperidone 6 mg daily, presents with 2 days of worsening confusion, ataxia, and tremors. Serum lithium is 3.2 mEq/L (toxic). She is treated with saline diuresis and recovers. Two weeks later, she is readmitted with recurrence of severe lithium toxicity (level 3.5 mEq/L) despite taking only prescribed lithium. Renal function is normal. Which of the following medication interactions most likely explains the recurrent toxicity?", "options": ["Paliperidone inhibiting renal tubular secretion of lithium", "Undiagnosed nephrogenic diabetes insipidus causing dehydration", "Nonsteroidal anti-inflammatory drug use reducing lithium clearance", "Thiazide diuretic prescribed for pedal edema", "Lithium tablet malabsorption with erratic bioavailability"], "answer": "D", "answer_index": 3, "explanation": "Thiazide diuretics cause sodium depletion, increasing renal lithium reabsorption and dramatically elevating serum levels, even with previously stable dosing. The time course fits with recent thiazide prescription after initial hospitalization. NSAIDs also reduce lithium clearance but typically less dramatically. Paliperidone has no known effect on lithium handling. Nephrogenic DI causes polyuria but not necessarily toxicity unless dehydration occurs. Malabsorption would lower, not increase, levels. Thiazides are often prescribed for lithium-induced edema or hypertension, creating this dangerous interaction that must be avoided in lithium-treated patients.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question asks to identify the cause of recurrent lithium toxicity in a patient with 'normal renal function.' The key discriminator is the renal function status. NSAIDs (Option C) typically cause lithium toxicity by reducing renal blood flow and GFR (hemodynamic AKI). In contrast, thiazide diuretics (Option D) increase lithium levels primarily by increasing proximal tubular reabsorption of lithium (compensatory to distal sodium loss), which can theoretically elevate levels significantly even with preserved GFR initially. Therefore, the constraint 'Renal function is normal' effectively rules out the NSAID mechanism (which relies on GFR reduction) and points to the tubular reabsorption mechanism (Thiazide). Additionally, Option D provides a specific clinical context ('prescribed for pedal edema,' a known side effect of lithium) that links the events logically, whereas Option C is generic. The phrase 'taking only prescribed lithium' is slightly ambiguous (could imply no other meds) but in context is intended to rule out intentional lithium overdose, not the presence of a new co-prescription. The item is logically valid as a 'most likely' diagnosis of cause.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question asks to identify the cause of recurrent lithium toxicity in a patient with 'normal renal function.' The key discriminator is the renal function status. NSAIDs (Option C) typically cause lithium toxicity by reducing renal blood flow and GFR (hemodynamic AKI). In contrast, thiazide diuretics (Option D) increase lithium levels primarily by increasing proximal tubular reabsorption of lithium (compensatory to distal sodium loss), which can theoretically elevate levels significantly even with preserved GFR initially. Therefore, the constraint 'Renal function is normal' effectively rules out the NSAID mechanism (which relies on GFR reduction) and points to the tubular reabsorption mechanism (Thiazide). Additionally, Option D provides a specific clinical context ('prescribed for pedal edema,' a known side effect of lithium) that links the events logically, whereas Option C is generic. The phrase 'taking only prescribed lithium' is slightly ambiguous (could imply no other meds) but in context is intended to rule out intentional lithium overdose, not the presence of a new co-prescription. The item is logically valid as a 'most likely' diagnosis of cause.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-017", "question": "A 32-year-old man with borderline intellectual functioning presents with new-onset complex motor tics, coprolalia, and obsessive-compulsive symptoms. He had group A streptococcal pharyngitis 6 weeks prior. Anti-streptolysin O titer is 800 IU/mL. MRI brain shows increased T2 signal in basal ganglia. Which of the following immunomodulatory therapies has demonstrated efficacy in controlled trials for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)?", "options": ["Intravenous immunoglobulin (IVIG)", "Plasmapheresis", "Oral penicillin prophylaxis", "Intravenous methylprednisolone", "Rituximab"], "answer": "A", "answer_index": 0, "explanation": "While evidence for PANDAS treatments is limited, the randomized controlled trial by Perlmutter et al. (1999) in Lancet demonstrated that IVIG and plasmapheresis were superior to placebo for symptom reduction. IVIG is generally preferred first-line due to lower morbidity than plasmapheresis. Oral penicillin prevents new streptococcal infections but doesn't treat active neuropsychiatric symptoms. IV steroids have anecdotal support but no controlled trial evidence. Rituximab has case reports but no controlled trials. The question specifies proven efficacy in controlled trials, making IVIG (and plasmapheresis) correct, but IVIG is more commonly used as initial immunomodulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item contains significant medical and logical flaws. First, the vignette describes a 32-year-old man with 'PANDAS' (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). By definition, PANDAS requires prepubertal onset; applying this diagnosis to a 32-year-old is medically inaccurate (adult-onset cases are classified differently, e.g., PANS or autoimmune encephalitis). Second, the question asks which therapy has 'demonstrated efficacy in controlled trials.' The seminal randomized controlled trial (Perlmutter et al., 1999) demonstrated efficacy for *both* IVIG (Option A) and Plasmapheresis (Option B) compared to placebo. Without a qualifier such as 'most appropriate initial therapy' or 'least invasive,' there is no basis to exclude Plasmapheresis, making the item have two equally correct answers based on the cited evidence. Furthermore, a subsequent RCT (Williams et al., 2016) failed to replicate IVIG efficacy, complicating the 'demonstrated efficacy' claim for Option A. The item is logically invalid due to multiple defensible answers and medically flawed due to the age/diagnosis contradiction.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item contains significant medical and logical flaws. First, the vignette describes a 32-year-old man with 'PANDAS' (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). By definition, PANDAS requires prepubertal onset; applying this diagnosis to a 32-year-old is medically inaccurate (adult-onset cases are classified differently, e.g., PANS or autoimmune encephalitis). Second, the question asks which therapy has 'demonstrated efficacy in controlled trials.' The seminal randomized controlled trial (Perlmutter et al., 1999) demonstrated efficacy for *both* IVIG (Option A) and Plasmapheresis (Option B) compared to placebo. Without a qualifier such as 'most appropriate initial therapy' or 'least invasive,' there is no basis to exclude Plasmapheresis, making the item have two equally correct answers based on the cited evidence. Furthermore, a subsequent RCT (Williams et al., 2016) failed to replicate IVIG efficacy, complicating the 'demonstrated efficacy' claim for Option A. The item is logically invalid due to multiple defensible answers and medically flawed due to the age/diagnosis contradiction.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-018", "question": "A 65-year-old man with recurrent high-grade non-muscle invasive bladder cancer (pT1G3) refractory to BCG and pembrolizumab undergoes radical cystoprostatectomy with ileal conduit. Pathology shows pT2aN0 disease. Six months postoperatively, surveillance CT reveals a 2.5 cm enhancing mass at the left ureteroileal anastomosis. Cystoscopy confirms extrinsic compression. Biopsy shows recurrent urothelial carcinoma. Which of the following management approaches is most appropriate?", "options": ["Systemic chemotherapy with gemcitabine and cisplatin", "Radiation therapy to the anastomotic bed", "Surgical resection with revision of ureteroileal anastomosis", "Intravesical BCG instillation via conduit", "Enfortumab vedotin or sacituzumab govitecan"], "answer": "B", "answer_index": 1, "explanation": "Isolated local recurrence after radical cystectomy with negative margins is rare but potentially curable with radiation therapy. Surgical revision risks extensive adhesions and may not achieve clear margins. Systemic chemotherapy is indicated for metastatic disease but overtreats isolated local recurrence. Intravesical therapy cannot reach the ureteroileal anastomosis. Antibody-drug conjugates like enfortumab are for metastatic disease post-chemo and immunotherapy. Radiation with curative intent (60-66 Gy) offers chance of durable local control without morbidity of reoperation, particularly in medically inoperable patients or those with challenging surgical anatomy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a 65-year-old man with a high-grade recurrence of urothelial carcinoma (2.5 cm mass) just 6 months after radical cystectomy. The standard of care for recurrent urothelial carcinoma following cystectomy is systemic therapy, as early recurrence implies aggressive biology and high risk of occult metastatic disease. For a patient who is chemotherapy-naïve (he received BCG and pembrolizumab for NMIBC, not systemic platinum-based chemo), the established first-line standard is cisplatin-based combination chemotherapy (Option A). While radiation therapy (Option B) can be used for local control in selected cases (often palliative or for those unfit for chemo), it is not the standard 'most appropriate' initial management for a fit patient with a first recurrence over systemic therapy. The author's rationale that chemotherapy 'overtreats' isolated local recurrence contradicts major guidelines (e.g., NCCN), which recommend systemic therapy as the primary approach for recurrence. Consequently, Option A is the defensible best answer, while the provided key (B) represents a niche or palliative approach. The item is miskeyed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a 65-year-old man with a high-grade recurrence of urothelial carcinoma (2.5 cm mass) just 6 months after radical cystectomy. The standard of care for recurrent urothelial carcinoma following cystectomy is systemic therapy, as early recurrence implies aggressive biology and high risk of occult metastatic disease. For a patient who is chemotherapy-naïve (he received BCG and pembrolizumab for NMIBC, not systemic platinum-based chemo), the established first-line standard is cisplatin-based combination chemotherapy (Option A). While radiation therapy (Option B) can be used for local control in selected cases (often palliative or for those unfit for chemo), it is not the standard 'most appropriate' initial management for a fit patient with a first recurrence over systemic therapy. The author's rationale that chemotherapy 'overtreats' isolated local recurrence contradicts major guidelines (e.g., NCCN), which recommend systemic therapy as the primary approach for recurrence. Consequently, Option A is the defensible best answer, while the provided key (B) represents a niche or palliative approach. The item is miskeyed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-019", "question": "A 62-year-old man with metastatic renal cell carcinoma to L3 vertebra develops rapidly progressive cauda equina syndrome. He undergoes emergent L3 laminectomy with tumor debulking and posterior instrumentation. Postoperatively, he is unable to void and has perianal anesthesia. MRI shows residual tumor compressing the thecal sac. He is started on dexamethasone and referred for radiation oncology consultation. Which of the following radiotherapy parameters is most critical for optimizing neurological recovery while minimizing toxicity?", "options": ["Total dose of 30 Gy in 10 fractions", "Treatment volume limited to involved vertebral body only", "Omitting simultaneous integrated boost to macroscopic disease", "Avoiding concurrent vascular endothelial growth factor (VEGF) inhibitors", "Delaying radiotherapy until 4 weeks postoperatively"], "answer": "A", "answer_index": 0, "explanation": "For metastatic spinal cord compression with residual tumor post-decompression, 30 Gy in 10 fractions is the standard dose providing optimal balance of tumor control and spinal cord tolerance. Larger volumes including entire involved vertebra plus one above/below are needed to cover microscopic disease. Simultaneous boost increases cord toxicity risk. VEGF inhibitors can continue but with dose reduction if concurrent. Delaying radiation beyond 2 weeks increases recurrence risk; ideally start within 7-10 days postoperatively. The total dose-fractionation is most critical as single-fraction (8 Gy) provides less durable control, while higher doses (≥37.5 Gy) increase myelopathy risk without proven benefit.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a patient with metastatic renal cell carcinoma (RCC) and residual spinal cord compression after surgery. While RCC is radioresistant and SBRT is often preferred, the presence of residual tumor compressing the thecal sac generally precludes high-dose ablative SBRT due to spinal cord tolerance limits. Therefore, conventional fractionation (30 Gy in 10 fractions) is the appropriate standard of care to balance local control and neurological safety. Option A is the correct best answer. Option B describes an insufficient treatment volume (standard fields include the involved level plus margins/adjacent levels). Option E suggests an excessive delay; postoperative RT typically begins 2–3 weeks after surgery once the wound is sufficiently healed, and waiting 4 weeks risks rapid recurrence. Option D (avoiding VEGF inhibitors) describes concurrent systemic management; while holding TKIs is often recommended to reduce toxicity, it is not strictly a 'radiotherapy parameter' (like dose or volume) and is secondary to the fundamental radiation prescription. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a patient with metastatic renal cell carcinoma (RCC) and residual spinal cord compression after surgery. While RCC is radioresistant and SBRT is often preferred, the presence of residual tumor compressing the thecal sac generally precludes high-dose ablative SBRT due to spinal cord tolerance limits. Therefore, conventional fractionation (30 Gy in 10 fractions) is the appropriate standard of care to balance local control and neurological safety. Option A is the correct best answer. Option B describes an insufficient treatment volume (standard fields include the involved level plus margins/adjacent levels). Option E suggests an excessive delay; postoperative RT typically begins 2–3 weeks after surgery once the wound is sufficiently healed, and waiting 4 weeks risks rapid recurrence. Option D (avoiding VEGF inhibitors) describes concurrent systemic management; while holding TKIs is often recommended to reduce toxicity, it is not strictly a 'radiotherapy parameter' (like dose or volume) and is secondary to the fundamental radiation prescription. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "question_id": "20251219T221819110Z_deepseek-v3.2_seed132-020", "question": "A 58-year-old woman with BRCA2 mutation and bilateral breast cancer s/p bilateral mastectomies presents with isolated sternal metastasis. Biopsy confirms estrogen receptor-positive, HER2-negative adenocarcinoma of breast origin. She receives 30 Gy in 10 fractions to the sternum with good pain relief. Six months later, she develops new biopsy-proven breast cancer metastasis to the right humeral head within the previous radiation field. Which of the following factors most significantly increases the risk of radiation-associated second primary malignancy in this patient?", "options": ["Total radiation dose exceeding 30 Gy", "Concurrent hormonal therapy with aromatase inhibitor", "BRCA2 germline mutation", "Age >50 at time of irradiation", "Use of 3D-conformal rather than intensity-modulated radiotherapy"], "answer": "C", "answer_index": 2, "explanation": "BRCA2 mutations confer deficiency in homologous recombination DNA repair, dramatically increasing sensitivity to ionizing radiation and risk of radiation-induced second malignancies. Dose, technique, and age are minor factors compared to genetic predisposition. Concurrent aromatase inhibitors don't significantly increase radiation carcinogenesis. IMRT may increase low-dose bath but not necessarily secondary malignancy risk. The recurrence in-field is likely a recurrence rather than a radiation-induced second primary, but the question asks specifically about radiation-associated malignancy risk. BRCA2 carriers have 3-5 fold increased risk of radiation-induced cancers compared to non-carriers, mandating careful risk-benefit assessment for radiotherapy.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: C (Contradiction)\\nVerdict on keyed answer: No defensible answer / Factually questionable\\n\\nThe item contains a fatal anatomical contradiction: a standard 'sternal field' (medial chest) cannot anatomically include the 'humeral head' (lateral shoulder) unless the field was inappropriately large or the anatomy is grossly distorted. Additionally, the vignette describes a recurrence at 6 months, while the question asks about 'radiation-associated second primary malignancy,' which requires a latency of years to decades. This disconnect confuses the clinical picture. \\n\\nMedically, the key (BRCA2) is controversial. While BRCA mutations impair DNA repair, clinical data (e.g., WECARE study, various meta-analyses) generally show no significant or only a minimal increase in radiation-induced second malignancies (sarcomas/contralateral breast) for BRCA carriers, unlike Li-Fraumeni syndrome (TP53), where the risk is prohibitive. Stating that BRCA2 'most significantly' increases risk is not supported by consensus guidelines, which do not contraindicate radiation. Age (younger) is typically a stronger risk factor than BRCA status in this context. \\n\\nMinimal fix: Change the mutation to 'TP53 (Li-Fraumeni syndrome)' where the risk is undisputed, and correct the anatomy (e.g., 'chest wall' field) or site of recurrence.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction)\nVerdict on keyed answer: No defensible answer / Factually questionable\n\nThe item contains a fatal anatomical contradiction: a standard 'sternal field' (medial chest) cannot anatomically include the 'humeral head' (lateral shoulder) unless the field was inappropriately large or the anatomy is grossly distorted. Additionally, the vignette describes a recurrence at 6 months, while the question asks about 'radiation-associated second primary malignancy,' which requires a latency of years to decades. This disconnect confuses the clinical picture. \n\nMedically, the key (BRCA2) is controversial. While BRCA mutations impair DNA repair, clinical data (e.g., WECARE study, various meta-analyses) generally show no significant or only a minimal increase in radiation-induced second malignancies (sarcomas/contralateral breast) for BRCA carriers, unlike Li-Fraumeni syndrome (TP53), where the risk is prohibitive. Stating that BRCA2 'most significantly' increases risk is not supported by consensus guidelines, which do not contraindicate radiation. Age (younger) is typically a stronger risk factor than BRCA status in this context. \n\nMinimal fix: Change the mutation to 'TP53 (Li-Fraumeni syndrome)' where the risk is undisputed, and correct the anatomy (e.g., 'chest wall' field) or site of recurrence.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}]